Outcomes after extracorporeal life support for COVID-19 myocarditis: an analysis of the Extracorporeal Life Support Organization Registry

Crit Care. 2022 Aug 3;26(1):235. doi: 10.1186/s13054-022-04111-z.

Authors

Joseph E Tonna¹, Chuen Seng Tan², Kasia Hryniewicz³, Ryan P Barbaro⁴, Daniel Brodie⁵, Graeme MacLaren⁶

Affiliations

¹ The University of Utah School of Medicine, 30 N 1900 E, 3C127, Salt Lake City, UT, 84132, USA. joseph.tonna@hsc.utah.edu.
² National University of Singapore, Singapore, Singapore.
³ Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, MN, 84132, USA.
⁴ University of Michigan, Ann Arbor, MI, 84132, USA.
⁵ Columbia University, New York, NY, USA.
⁶ Cardiothoracic ICU, National University Hospital, Singapore, Singapore.

No abstract available

Keywords: Acute respiratory distress syndrome; Cardiac failure; Myocardial inflammation; Respiratory failure.

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

COVID-19* / therapy
Extracorporeal Membrane Oxygenation*
Hospital Mortality
Humans
Myocarditis* / therapy
Registries
Respiratory Insufficiency*
Retrospective Studies

Grants and funding